SIMPLEX TRADING, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is and the CUSIP is 140755959. A total of 4 filers reported holding CARA THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
SIMPLEX TRADING, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$0300
+50.0%
0.00%
Q2 2023$02000.0%0.00%
Q1 2023$0
-100.0%
200
-97.5%
0.00%
Q4 2022$86
-99.9%
8,100
+24.6%
0.00%
Q3 2022$60,000
+27.7%
6,500
+25.0%
0.00%
Q2 2022$47,000
-34.7%
5,200
-13.3%
0.00%
Q1 2022$72,000
-27.3%
6,000
-26.8%
0.00%
Q4 2021$99,000
+35.6%
8,200
+60.8%
0.00%
Q3 2021$73,000
+2.8%
5,100
+2.0%
0.00%
Q2 2021$71,000
-88.3%
5,000
+1692.1%
0.00%
-100.0%
Q1 2021$605,000
+557.6%
279
+357.4%
0.00%
Q4 2020$92,000
+2.2%
61
-14.1%
0.00%
Q3 2020$90,000
-73.4%
71
-64.1%
0.00%
-100.0%
Q2 2020$338,000
-5.8%
198
-27.2%
0.00%0.0%
Q1 2020$359,000
-7.7%
272
+12.4%
0.00%0.0%
Q4 2019$389,000
-8.3%
242
+4.3%
0.00%0.0%
Q3 2019$424,000
-34.3%
232
-22.7%
0.00%
-50.0%
Q2 2019$645,000
+61.2%
300
+47.1%
0.00%
+100.0%
Q1 2019$400,000
+156.4%
204
+70.0%
0.00%
Q4 2018$156,000
-55.3%
120
-17.8%
0.00%
-100.0%
Q3 2018$349,000
-76.1%
146
-80.9%
0.00%
-83.3%
Q2 2018$1,461,000
+11138.5%
763
+890.9%
0.01%
+500.0%
Q1 2018$13,000
-82.2%
77
-73.8%
0.00%
-66.7%
Q4 2017$73,000
+97.3%
294
+79.3%
0.00%
+50.0%
Q3 2017$37,000
-86.4%
164
-89.2%
0.00%
-83.3%
Q2 2017$272,000
+394.5%
1,525
+133.2%
0.01%
+500.0%
Q1 2017$55,000
+1000.0%
654
+688.0%
0.00%
Q4 2016$5,000
+66.7%
83
+36.1%
0.00%
Q3 2016$3,0000.0%61
+69.4%
0.00%
Q2 2016$3,000
+50.0%
36
-68.4%
0.00%
Q1 2016$2,000
-33.3%
114
+1166.7%
0.00%
Q3 2015$3,000
+200.0%
9
-71.9%
0.00%
Q2 2015$1,000320.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 130,200$2,799,0000.02%
SIMPLEX TRADING, LLC 300$645,0000.00%
JPMORGAN CHASE & CO 105,500$2,231,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of CARA THERAPEUTICS INC shareholders